05:05 AM EST, 11/13/2024 (MT Newswires) -- BioLife Solutions ( BLFS ) reported late Tuesday a Q3 net loss from continuing operations of $0.04 per diluted share, narrower than the $0.36 loss per share a year earlier.

Analysts polled by Capital IQ expected a loss of $0.08.

Revenue for the quarter ended Sept. 30 was $30.6 million, up from $23.6 million a year earlier.

Analysts polled by Capital IQ expected $25.4 million.

The company now expects 2024 revenue of $98 million to $100 million, compared with prior guidance of $99 million to $101 million. Analysts polled by Capital IQ are expecting $111.3 million.